Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and gaining access to a pipeline of projects.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to align interests and access a robust pipeline.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests with those who have a strong pipeline.

Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from a robust pipeline.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the San Diego life science market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests amid rising vacancy rates.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator at the GP level, focusing on those with a proven track record in managing laboratory spaces amidst current market headwinds.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from their expertise.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of lab space opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of developments.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a robust pipeline.

Co-GP / Platform:A family office could deploy into New York's life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a repeatable pipeline of deals.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of life sciences developments.

Co-GP / Platform:A family office could deploy into the Washington, D.C. life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor/operator at the GP level, focusing on those with strong pipelines and adaptive strategies in response to funding pressures.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator in a co-GP structure to share in the promote and access a pipeline of life sciences developments.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into this market by backing established life sciences operators at the GP level, sharing in the promote and benefiting from the ongoing construction of major facilities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a repeatable pipeline of investment opportunities.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator focused on biotech developments, sharing in the promote and benefiting from the growth of the sector.